BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29884554)

  • 1. The incidence of infantile hypertrophic pyloric stenosis and its association with folic acid supplementation during pregnancy: A nested case-control study.
    Rosenthal YS; Chodick G; Grossman Z; Shalev V; Koren G
    J Pediatr Surg; 2019 Apr; 54(4):701-706. PubMed ID: 29884554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and pregnancy characteristics and risk of infantile hypertrophic pyloric stenosis.
    Svenningsson A; Svensson T; Akre O; Nordenskjöld A
    J Pediatr Surg; 2014 Aug; 49(8):1226-31. PubMed ID: 25092081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Maternal Omega 3 Supplementation Protect Against Infantile Hypertrophic Pyloric Stenosis?
    Paran M; Freud E; Samuk I; Steiner Z
    J Pediatr Gastroenterol Nutr; 2020 May; 70(5):652-656. PubMed ID: 31990865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.
    Abdellatif M; Ghozy S; Kamel MG; Elawady SS; Ghorab MME; Attia AW; Le Huyen TT; Duy DTV; Hirayama K; Huy NT
    Eur J Pediatr; 2019 Mar; 178(3):301-314. PubMed ID: 30470884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.
    Almaramhy HH; Al-Zalabani AH
    Ital J Pediatr; 2019 Feb; 45(1):20. PubMed ID: 30717812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study.
    Lund M; Pasternak B; Davidsen RB; Feenstra B; Krogh C; Diaz LJ; Wohlfahrt J; Melbye M
    BMJ; 2014 Mar; 348():g1908. PubMed ID: 24618148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population-based retrospective study, 1999-2010.
    Kapoor R; Kancherla V; Cao Y; Oleson J; Suhl J; Canfield MA; Druschel CM; Kirby RS; Meyer RE; Romitti PA
    Birth Defects Res; 2019 Feb; 111(3):159-169. PubMed ID: 30549250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of prematurity with the development of infantile hypertrophic pyloric stenosis.
    Stark CM; Rogers PL; Eberly MD; Nylund CM
    Pediatr Res; 2015 Aug; 78(2):218-22. PubMed ID: 25950452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental exposure in the etiology of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.
    Boybeyi-Turer O; Celik HT; Arslan UE; Soyer T; Tanyel FC; Kiran S
    Pediatr Surg Int; 2022 Jul; 38(7):951-961. PubMed ID: 35441884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal factors in the origin of infantile hypertrophic pyloric stenosis: A population-based case-control study.
    Vermes G; László D; Czeizel AE; Ács N
    Congenit Anom (Kyoto); 2016 Mar; 56(2):65-72. PubMed ID: 26394719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile hypertrophic pyloric stenosis: maternal diabetes and perinatal exposure to non-macrolide antibiotics.
    Cohen Elias S; Yarza S; Yerushalmi B; Shany E; Marks KA
    J Perinatol; 2023 Apr; 43(4):465-469. PubMed ID: 36702873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal risk factors for infantile hypertrophic pyloric stenosis: A meta-analysis.
    Zhu J; Zhu T; Lin Z; Qu Y; Mu D
    J Pediatr Surg; 2017 Sep; 52(9):1389-1397. PubMed ID: 28318599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?
    Hauben M; Amsden GW
    Drug Saf; 2002; 25(13):929-42. PubMed ID: 12381214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing epidemiology of infantile hypertrophic pyloric stenosis in Scotland.
    Sommerfield T; Chalmers J; Youngson G; Heeley C; Fleming M; Thomson G
    Arch Dis Child; 2008 Dec; 93(12):1007-11. PubMed ID: 18285388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyloric Stenosis: National Trends in the Incidence Rate and Resource Use in the United States From 2012 to 2016.
    Donda K; Asare-Afriyie B; Ayensu M; Sharma M; Amponsah JK; Bhatt P; Hesse MA; Dapaah-Siakwan F
    Hosp Pediatr; 2019 Dec; 9(12):923-932. PubMed ID: 31748239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile hypertrophic pyloric stenosis: a comparative study of incidence and other epidemiological characteristics in seven European regions.
    Pedersen RN; Garne E; Loane M; Korsholm L; Husby S;
    J Matern Fetal Neonatal Med; 2008 Sep; 21(9):599-604. PubMed ID: 18828050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in infantile hypertrophic pyloric stenosis in Germany in 2000-2008.
    de Laffolie J; Turial S; Heckmann M; Zimmer KP; Schier F
    Pediatrics; 2012 Apr; 129(4):e901-6. PubMed ID: 22430445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis.
    Cooper WO; Ray WA; Griffin MR
    Obstet Gynecol; 2002 Jul; 100(1):101-6. PubMed ID: 12100810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth outcomes of male and female patients with infantile hypertrophic pyloric stenosis--a population-based case-control study.
    Vermes G; Mátrai Á; Czeizel AE; Ács N
    J Matern Fetal Neonatal Med; 2016; 29(11):1777-82. PubMed ID: 26135791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conservative treatment of hypertrophic pyloric stenosis in children].
    Sretenović A; Smoljanić Z; Korać G; Sindjeć S; Lukac M; Krstić Z
    Srp Arh Celok Lek; 2004 Oct; 132 Suppl 1():93-6. PubMed ID: 15615476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.